MENU

Iberia Romina Sosa, MD, PhD

Department of Hematology/Oncology

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

About

Assistant Professor

Treatment Focus

Consultative hematology with a focus on myeloproliferative disorders, bleeding/thrombosis and bone marrow failure.

Language(s) Other than English

Spanish

Treatment Philosophy

My treatment philosophy is to deliver personalized care that integrates the latest developments in science, while keeping in mind the individual’s personal goals.  I encourage my patients to be active participants in their care and I value the trust they place upon me as their provider.

Education and Training

Educational Background

  • Postdoctoral Fellow, Vanderbilt University, Department of Medicine, Department of Medicine, Division of Clinical Pharmacology, Nashville, TN, 2014
  • Fellow, Hematology/Oncology, Vanderbilt University, Department of Medicine, Division of Hematology/Oncology , Nashville, TN, 2012
  • Residency, Vanderbilt University, Department of Medicine, Division of Hematology/Oncology , Nashville, TN, 2009
  • MD, University of Minnesota Medical School, Minneapolis, MN, 2007
  • PhD, Neuroscience, University of Minnesota, Minneapolis, MN, 2005
  • MS  in Science,  Zoology  and Physiology, Louisiana State University, Baton Rouge, LA, 1999

Certifications

  • Hematology, American Board Internal Medicine
  • Internal Medicine, American Board Internal Medicine

Memberships

  • American Heart Association, Early Career Member 
  • American Society of Clinical Oncology, Associate Member
  • American Society of Hematology, Associate Member
  • Hemostasis and Thrombosis Research Society, Associate Member
  • International Society on Thrombosis  and Haemostasis,  Member
  • MRA Reviewer since 2014
  • SWOG/NCI  Cancer  Research  Cooperative  Group,  Member 

Honors & Awards

  • That's the Way Player of the Month Award: Award for dedication and exceptional service to patient care, January 2018.
  • Travel Award Recipient, Hemostasis and Thrombosis Research Society, May 2017
Research Profile

Research Interests

Cancer associated thrombosis

Ongoing Clinical Trial Studies
  • USE OF METFORMIN AS A FETAL HEMOGLOBIN INDUCER IN PATIENTS WITH HEMOGLOBINOPATHIES (FITMET)
    (Pl: Vivien Sheehan, MD, PhD). Phizer, Inc. Role: Co-Investigator.
  • SAMPLE COLLECTION FOR DEVELOPMENT OF A NON-INVASIVE PRENATAL TEST FOR HEMOGLOBINOPATHIES. (Pl: Vivien
    Sheehan, MD, PhD). Billion To One. Role: Co-Investigator.
  • RESVERATROL IN METABOLIC SYNDROME: EFFECT ON PLATELET HYPER-REACTIVITY AND HDL LIPID PEROXIDATION.
    (Pl: Iberia R Sosa). American Heart Association. Role: Pl
  • COMPARISON OF ORAL ANTICOAGULANTS FOR EXTENDED VENOUS THROMBOEMBOLISM (COVET).
    (Pl: Thomas Orte!, MD, PhD). Patient Centered Outcomes Research Institute. Role: Site Pl.
  • 551: PILOT STUDY OF SERTRALINE IN TREATMENT OF LOW-RISK MYELODYSPLASTIC SYNDROME.
    (Pl: Gustavo Rivero, MD). Golfers Against Cancer. Role: Co-Investigator
Publications

Selected Publications

R. Sosa, S. Li, J.T. Molony, J. Liu, S. Stryker, AJ Collins. Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A Systematic Review of the Medicare Database. Supportive Care in Cancer. 2017 Apr 29. [PMID: 28456908]

0. Boutaud, I. R. Sosa, T. Amin, G. Milne, D. Adler, H.S. Hwang, B. Crews, G.L. Milne, B.K. Harris, M.D. Hoeksema,

B.C. Knowllmann, P.E. Lammers, L.J. Marnett, P.P. Massion, J. A. Oates JA. Aspirin inhibits prostaglandin Ez production by lung adenocarcinoma cells by direct and platelet mediated interactions. Cancer Prevention Research. 2016 Nov;9(11):855-865. [PMID: 27554763].

I. Zagol-lkapite, I.R. Sosa, D. Oram, A. Judd, K. Amarnath, D. Stec, J. Oates, 0. Boutaud. Modification of platelet proteins by malondialdehyde: prevention by dicarbonyl scavengers. Journal of Lipid Research. 2015 Nov; 56(11):21960205. [PMID: 26378094].

I.R. Sosa, D. Gailani and A.T. Neff. Development of FXIII inhibitor in a patient with congenital FXIII deficiency receiving interferon and ribavarin therapy for chronic hepatitis C infection. Haemophilia: 2014 Nov;20(6): e429-32. [PMID: 25333572].

I.R. Sosa, P. Ellery, A. Mast, A.T. Neff and D. Gailani. Acquired Factor V deficiency in a patient without evidence of a classical inhibitor. Haemophilia: 2014 Jan; 20(1): e81-3. [PMID: 24118596].

B. Taylor, R.Sosa, W.M. Stone. Bromide Toxicity from Consumption of Dead Sea Salt, American Journal of Medicine. American Journal of Medicine: 2010 Mar;123(3): ell-2. [PMID: 20193810].

R. Sosa and E. Gleason.  Activation of mGluRS modulates calcium currents in retinal amacrine cells1   Visual Neuroscience, 21: 807-816, 2004. [PMID:15733336]

R. Sosa, B. Hoffpauir, M. Rankin, R. Bruch and E. Gleason. Metabotropic glutamate receptor 5 and calcium signaling in retinal amacrine cells. Journal of Neurachemistry 81(5): 973-83, 2002. [PMID: 12065609].

Book Chapters

R. Sosa, and M. Udden (2017). Critical Care in Obstetrics. In M. Belfort, J. Phelan, G. Saade, M. Foley. Sickle Cell Disease and Pregnancy. (in press)

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

Assistant Professor

Treatment Focus

Consultative hematology with a focus on myeloproliferative disorders, bleeding/thrombosis and bone marrow failure.

Language(s) Other than English

Spanish

Treatment Philosophy

My treatment philosophy is to deliver personalized care that integrates the latest developments in science, while keeping in mind the individual’s personal goals.  I encourage my patients to be active participants in their care and I value the trust they place upon me as their provider.

Education

Educational Background

  • Postdoctoral Fellow, Vanderbilt University, Department of Medicine, Department of Medicine, Division of Clinical Pharmacology, Nashville, TN, 2014
  • Fellow, Hematology/Oncology, Vanderbilt University, Department of Medicine, Division of Hematology/Oncology , Nashville, TN, 2012
  • Residency, Vanderbilt University, Department of Medicine, Division of Hematology/Oncology , Nashville, TN, 2009
  • MD, University of Minnesota Medical School, Minneapolis, MN, 2007
  • PhD, Neuroscience, University of Minnesota, Minneapolis, MN, 2005
  • MS  in Science,  Zoology  and Physiology, Louisiana State University, Baton Rouge, LA, 1999

Certifications

  • Hematology, American Board Internal Medicine
  • Internal Medicine, American Board Internal Medicine

Memberships

  • American Heart Association, Early Career Member 
  • American Society of Clinical Oncology, Associate Member
  • American Society of Hematology, Associate Member
  • Hemostasis and Thrombosis Research Society, Associate Member
  • International Society on Thrombosis  and Haemostasis,  Member
  • MRA Reviewer since 2014
  • SWOG/NCI  Cancer  Research  Cooperative  Group,  Member 

Honors & Awards

  • That's the Way Player of the Month Award: Award for dedication and exceptional service to patient care, January 2018.
  • Travel Award Recipient, Hemostasis and Thrombosis Research Society, May 2017

Research Profile

Research Interests

Cancer associated thrombosis

Ongoing Clinical Trial Studies
  • USE OF METFORMIN AS A FETAL HEMOGLOBIN INDUCER IN PATIENTS WITH HEMOGLOBINOPATHIES (FITMET)
    (Pl: Vivien Sheehan, MD, PhD). Phizer, Inc. Role: Co-Investigator.
  • SAMPLE COLLECTION FOR DEVELOPMENT OF A NON-INVASIVE PRENATAL TEST FOR HEMOGLOBINOPATHIES. (Pl: Vivien
    Sheehan, MD, PhD). Billion To One. Role: Co-Investigator.
  • RESVERATROL IN METABOLIC SYNDROME: EFFECT ON PLATELET HYPER-REACTIVITY AND HDL LIPID PEROXIDATION.
    (Pl: Iberia R Sosa). American Heart Association. Role: Pl
  • COMPARISON OF ORAL ANTICOAGULANTS FOR EXTENDED VENOUS THROMBOEMBOLISM (COVET).
    (Pl: Thomas Orte!, MD, PhD). Patient Centered Outcomes Research Institute. Role: Site Pl.
  • 551: PILOT STUDY OF SERTRALINE IN TREATMENT OF LOW-RISK MYELODYSPLASTIC SYNDROME.
    (Pl: Gustavo Rivero, MD). Golfers Against Cancer. Role: Co-Investigator

Publications

Selected Publications

R. Sosa, S. Li, J.T. Molony, J. Liu, S. Stryker, AJ Collins. Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A Systematic Review of the Medicare Database. Supportive Care in Cancer. 2017 Apr 29. [PMID: 28456908]

0. Boutaud, I. R. Sosa, T. Amin, G. Milne, D. Adler, H.S. Hwang, B. Crews, G.L. Milne, B.K. Harris, M.D. Hoeksema,

B.C. Knowllmann, P.E. Lammers, L.J. Marnett, P.P. Massion, J. A. Oates JA. Aspirin inhibits prostaglandin Ez production by lung adenocarcinoma cells by direct and platelet mediated interactions. Cancer Prevention Research. 2016 Nov;9(11):855-865. [PMID: 27554763].

I. Zagol-lkapite, I.R. Sosa, D. Oram, A. Judd, K. Amarnath, D. Stec, J. Oates, 0. Boutaud. Modification of platelet proteins by malondialdehyde: prevention by dicarbonyl scavengers. Journal of Lipid Research. 2015 Nov; 56(11):21960205. [PMID: 26378094].

I.R. Sosa, D. Gailani and A.T. Neff. Development of FXIII inhibitor in a patient with congenital FXIII deficiency receiving interferon and ribavarin therapy for chronic hepatitis C infection. Haemophilia: 2014 Nov;20(6): e429-32. [PMID: 25333572].

I.R. Sosa, P. Ellery, A. Mast, A.T. Neff and D. Gailani. Acquired Factor V deficiency in a patient without evidence of a classical inhibitor. Haemophilia: 2014 Jan; 20(1): e81-3. [PMID: 24118596].

B. Taylor, R.Sosa, W.M. Stone. Bromide Toxicity from Consumption of Dead Sea Salt, American Journal of Medicine. American Journal of Medicine: 2010 Mar;123(3): ell-2. [PMID: 20193810].

R. Sosa and E. Gleason.  Activation of mGluRS modulates calcium currents in retinal amacrine cells1   Visual Neuroscience, 21: 807-816, 2004. [PMID:15733336]

R. Sosa, B. Hoffpauir, M. Rankin, R. Bruch and E. Gleason. Metabotropic glutamate receptor 5 and calcium signaling in retinal amacrine cells. Journal of Neurachemistry 81(5): 973-83, 2002. [PMID: 12065609].

Book Chapters

R. Sosa, and M. Udden (2017). Critical Care in Obstetrics. In M. Belfort, J. Phelan, G. Saade, M. Foley. Sickle Cell Disease and Pregnancy. (in press)

Connect with Fox Chase